Shopping Cart
- Remove All
- Your shopping cart is currently empty
PR-924 is a selective inhibitor of tripeptide epoxyketone immunoproteasome subunit LMP-7 (IC50: 22 nM). PR-924 inhibits growth and triggers apoptosis in multiple myeloma (MM) cells. PR-924 has antitumor activities. PR-924 covalently modifies proteasomal N-terminal threonine active sites.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $722 | 5 days | |
1 mL x 10 mM (in DMSO) | $1,820 | 5 days |
Description | PR-924 is a selective inhibitor of tripeptide epoxyketone immunoproteasome subunit LMP-7 (IC50: 22 nM). PR-924 inhibits growth and triggers apoptosis in multiple myeloma (MM) cells. PR-924 has antitumor activities. PR-924 covalently modifies proteasomal N-terminal threonine active sites. |
Targets&IC50 | LMP2:8.2 μM, LMP7:22 nM |
Molecular Weight | 618.72 |
Formula | C37H38N4O5 |
Cas No. | 1416709-79-9 |
Relative Density. | 1.291 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.